These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 35868215

  • 21. Anti-Glycolipid Antibody Examination in Five EAE Models and Theiler's Virus Model of Multiple Sclerosis: Detection of Anti-GM1, GM3, GM4, and Sulfatide Antibodies in Relapsing-Remitting EAE.
    Moriguchi K, Nakamura Y, Park AM, Sato F, Kuwahara M, Khadka S, Omura S, Ahmad I, Kusunoki S, Tsunoda I.
    Int J Mol Sci; 2023 Aug 18; 24(16):. PubMed ID: 37629117
    [Abstract] [Full Text] [Related]

  • 22. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.
    Sonobe Y, Jin S, Wang J, Kawanokuchi J, Takeuchi H, Mizuno T, Suzumura A.
    Tohoku J Exp Med; 2007 Dec 18; 213(4):329-39. PubMed ID: 18075237
    [Abstract] [Full Text] [Related]

  • 23. Interleukin-15 enhances proinflammatory T-cell responses in patients with MS and EAE.
    Laurent C, Deblois G, Clénet ML, Carmena Moratalla A, Farzam-Kia N, Girard M, Duquette P, Prat A, Larochelle C, Arbour N.
    Neurol Neuroimmunol Neuroinflamm; 2021 Jan 18; 8(1):. PubMed ID: 33323466
    [Abstract] [Full Text] [Related]

  • 24. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
    Ingwersen J, Wingerath B, Graf J, Lepka K, Hofrichter M, Schröter F, Wedekind F, Bauer A, Schrader J, Hartung HP, Prozorovski T, Aktas O.
    J Neuroinflammation; 2016 Feb 26; 13():48. PubMed ID: 26920550
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Icariin ameliorates the progression of experimental autoimmune encephalomyelitis by down-regulating the major inflammatory signal pathways in a mouse relapse-remission model of multiple sclerosis.
    Cong H, Zhang M, Chang H, Du L, Zhang X, Yin L.
    Eur J Pharmacol; 2020 Oct 15; 885():173523. PubMed ID: 32871176
    [Abstract] [Full Text] [Related]

  • 29. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
    Rostami A, Ciric B.
    J Neurol Sci; 2013 Oct 15; 333(1-2):76-87. PubMed ID: 23578791
    [Abstract] [Full Text] [Related]

  • 30. IL-9 Controls Central Nervous System Autoimmunity by Suppressing GM-CSF Production.
    Yoshimura S, Thome R, Konno S, Mari ER, Rasouli J, Hwang D, Boehm A, Li Y, Zhang GX, Ciric B, Rostami A.
    J Immunol; 2020 Feb 01; 204(3):531-539. PubMed ID: 31852750
    [Abstract] [Full Text] [Related]

  • 31. IL-37 exerts therapeutic effects in experimental autoimmune encephalomyelitis through the receptor complex IL-1R5/IL-1R8.
    Sánchez-Fernández A, Zandee S, Amo-Aparicio J, Charabati M, Prat A, Garlanda C, Eisenmesser EZ, Dinarello CA, López-Vales R.
    Theranostics; 2021 Feb 01; 11(1):1-13. PubMed ID: 33391457
    [Abstract] [Full Text] [Related]

  • 32. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
    Feng M, Shu Y, Yang Y, Zheng X, Li R, Wang Y, Dai Y, Qiu W, Lu Z, Hu X.
    Neurochem Int; 2014 Jan 01; 64():64-72. PubMed ID: 24274996
    [Abstract] [Full Text] [Related]

  • 33. Ingested (Oral) Adrenocorticotropic Hormone Inhibits IL-17 in the Central Nervous System in the Mouse Model of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
    Dittel LJ, Dittel BN, Brod SA.
    Immunohorizons; 2022 Jul 22; 6(7):497-506. PubMed ID: 35868840
    [Abstract] [Full Text] [Related]

  • 34. Efficacy of Heshouwu () on gut mircobiota in mice with autoimmune encephalomyelitis.
    Jun Z, Junhua W, Xiaobing LI, Chenyi W, Fangjun LI, Yanni L, Hao C, Meiying S.
    J Tradit Chin Med; 2023 Aug 22; 43(4):676-685. PubMed ID: 37454252
    [Abstract] [Full Text] [Related]

  • 35. Impact of suppressing retinoic acid-related orphan receptor gamma t (ROR)γt in ameliorating central nervous system autoimmunity.
    Yang Y, Winger RC, Lee PW, Nuro-Gyina PK, Minc A, Larson M, Liu Y, Pei W, Rieser E, Racke MK, Lovett-Racke AE.
    Clin Exp Immunol; 2015 Jan 22; 179(1):108-18. PubMed ID: 25142403
    [Abstract] [Full Text] [Related]

  • 36. Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation.
    Hao J, Campagnolo D, Liu R, Piao W, Shi S, Hu B, Xiang R, Zhou Q, Vollmer T, Van Kaer L, La Cava A, Shi FD.
    Ann Neurol; 2011 Apr 22; 69(4):721-34. PubMed ID: 21425186
    [Abstract] [Full Text] [Related]

  • 37. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
    Hu X, Qin X.
    Int J Mol Med; 2013 May 22; 31(5):1209-21. PubMed ID: 23525227
    [Abstract] [Full Text] [Related]

  • 38. IL-12Rβ2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis.
    Xie C, Ciric B, Yu S, Zhang GX, Rostami A.
    J Neuroimmunol; 2016 Feb 15; 291():59-69. PubMed ID: 26857496
    [Abstract] [Full Text] [Related]

  • 39. Tehranolid and Artemisinin Effects on Ameliorating Experimental Autoimmune Encephalomyelitis by Modulating Inflammation and Remyelination.
    Salehi N, Nourbakhsh M, Noori S, Rezaeizadeh H, Zarghi A.
    Mol Neurobiol; 2023 Oct 15; 60(10):5975-5986. PubMed ID: 37391648
    [Abstract] [Full Text] [Related]

  • 40. Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTES.
    Matsui M, Weaver J, Proudfoot AE, Wujek JR, Wei T, Richer E, Trapp BD, Rao A, Ransohoff RM.
    J Neuroimmunol; 2002 Jul 15; 128(1-2):16-22. PubMed ID: 12098506
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.